Between Dec 22, 2025 and Jan 5, 2026, items can be submitted to the UDC and DRUM, but will not be processed until after the break. Staff will not be available to answer email during this period, and will not be able to provide DOIs for datasets until after Jan 5. If you are in need of a DOI during this period, consider Figshare, Zenodo, Open Science Framework, Harvard Dataverse or OpenICPSR.

Evaluating Primary Myelodysplastic Syndrome in Acute Myeloid Leukemia Patients

Loading...
Thumbnail Image

View/Download File

Persistent link to this item

Statistics
View Statistics

Journal Title

Journal ISSN

Volume Title

Published Date

Publisher

Abstract

The prognostic outcome of acute myelogenous leukemia (AML) patients with a history of myelodysplastic syndrome is significantly worse than those without prior MDS. It is thought that approximately 40% of AML multilineage dysplasia (MLD) patients have a history of MDS. In this study a pool of AML-MLD patients were retrospectively investigated for primary MDS.

Description

Faculty mentor: Erica Warlick, MD

Related to

Replaces

License

Series/Report Number

Funding information

This research was supported by the Undergraduate Research Opportunities Program (UROP).

Isbn identifier

Doi identifier

Previously Published Citation

Other identifiers

Suggested citation

Hoff, Gretchen. (2012). Evaluating Primary Myelodysplastic Syndrome in Acute Myeloid Leukemia Patients. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/133451.

Content distributed via the University Digital Conservancy may be subject to additional license and use restrictions applied by the depositor. By using these files, users agree to the Terms of Use. Materials in the UDC may contain content that is disturbing and/or harmful. For more information, please see our statement on harmful content in digital repositories.